건강기능식품 개발 지원을 위한 플랫폼 시스템
    1.
    发明公开
    건강기능식품 개발 지원을 위한 플랫폼 시스템 无效
    支持卫生功能食品开发的平台系统

    公开(公告)号:KR1020130089969A

    公开(公告)日:2013-08-13

    申请号:KR1020120006006

    申请日:2012-01-19

    CPC classification number: Y02P90/30 G06Q50/04 G06Q50/22 H04B5/02

    Abstract: PURPOSE: A one stop platform system establishes libraries required to develop a functional food by unit technology and provides those having a development demand for functional foods with relevant information in a comprehensive manner. CONSTITUTION: A database (140) contains a first library (210) having information about the functionality of several ingredients of a functional food and a second library (230) having information about the raw materials and manufacturing processes corresponding to each ingredient of the first library. An input/output module communicates with a user device. By using the information of the first library and the second library as well as the relations between the two libraries, a management module selectively provides the user device with the functionality information or the raw material/manufacturing process information of a certain functional food via the input/output module. [Reference numerals] (210) Functional material library; (230) Raw material normalization and manufacturing process library; (250) Functionality evaluation library; (AA) Raw material information; (B1) Function/reference component analysis method (1); (B2) Function/reference component analysis method (2); (B3) Function/reference component analysis method (3); (CC) Processing information; (D1) Extracting process (1); (D2) Extracting process (2); (D3) Powdering process (1); (D4) Powdering process (2); (EE) Material-specific functionality information; (F1) Raw material A; (F10,F15,J2,L5) Functionality B; (F11,F16,J3) Functionality C; (F12,F17) Functionality D; (F13,F18) Functionality E; (F19) Human body applying test document; (F2) Material A1; (F20) Animal test document; (F21) In vitro test document; (F3) Material A2; (F4) Material A3; (F5) Raw material B; (F6) Material B1; (F7) Material B2; (F8) Material B3; (F9,F14,J1,L1) Functionality A; (GG) Material-specific traditional purpose; (H1) Material A; (H2) Material B; (H3) Material C; (H4,H5,H6) Traditional purpose; (II) Functionality screening; (J4,J5,J6,L2,L6) In vitro test; (KK) Functionality evaluation; (L3,L7) In vivo test; (L4,L8) Human body test

    Abstract translation: 目的:一站式平台系统建立了以单位技术开发功能性食品所需的图书馆,并为具有综合性的相关信息功能食品开发需求提供了依据。 构成:数据库(140)包含第一库(210),其具有关于功能食品的若干成分的功能的信息,以及第二库(230),其具有关于与第一库的每个成分对应的原材料和制造过程的信息 。 输入/输出模块与用户设备进行通信。 通过使用第一库和第二库的信息以及两个库之间的关系,管理模块通过输入有选择地向用户设备提供功能信息或特定功能食品的原材料/制造过程信息 /输出模块。 (附图标记)(210)功能材料库; (230)原料标准化与制造过程库; (250)功能评估库; (AA)原材料信息; (B1)功能/参考成分分析方法(1); (B2)功能/参考分量分析方法(2); (B3)功能/参考分量分析方法(3); (CC)处理信息; (D1)提取工序(1); (D2)提取过程(2); (D3)粉化工序(1); (D4)粉化工序(2); (EE)材料特定功能信息; (F1)原料A; (F10,F15,J2,L5)功能B; (F11,F16,J3)功能C; (F12,F17)功能D; (F13,F18)功能E; (F19)人体应用测试文件; (F2)材料A1; (F20)动物试验文件; (F21)体外试验文件; (F3)材料A2; (F4)材料A3; (F5)原料B; (F6)材料B1; (F7)材料B2; (F8)材料B3; (F9,F14,J1,L1)功能A; (GG)物质专用传统用途; (H1)材料A; (H2)材料B; (H3)材料C; (H4,H5,H6)传统用途; (二)功能筛选; (J4,J5,J6,L2,L6)体外试验; (KK)功能评估; (L3,L7)体内试验; (L4,L8)人体试验

    엘루테로사이드 E를 포함하는 인슐린 저항성 또는 인슐린 저항성 관련 질환의 예방 또는 치료용 조성물
    2.
    发明公开
    엘루테로사이드 E를 포함하는 인슐린 저항성 또는 인슐린 저항성 관련 질환의 예방 또는 치료용 조성물 有权
    用于预防或治疗包含ELEUTHEROSIDE E的胰岛素抵抗或胰岛素抵抗相关疾病的组合物

    公开(公告)号:KR1020140118967A

    公开(公告)日:2014-10-08

    申请号:KR1020140118920

    申请日:2014-09-05

    Abstract: The present invention relates to a pharmaceutical composition and a health functional food to prevent or treat insulin resistance or insulin resistance-related diseases comprising Eleutheroside E as an active ingredient. The present invention is effective in regulating blood sugar, alleviating glucose tolerance, alleviating insulin resistance, and reducing insulin in blood; thereby being useful to prevent and treat insulin resistance or insulin resistance-related diseases.

    Abstract translation: 本发明涉及一种药物组合物和用于预防或治疗胰岛素抵抗或胰岛素抵抗相关疾病的健康功能食品,其包含伊柳塞罗E作为活性成分。 本发明有效调节血糖,缓解葡萄糖耐量,减轻胰岛素抵抗,降低血液中的胰岛素; 从而有助于预防和治疗胰岛素抵抗或胰岛素抵抗相关疾病。

    엘루테로사이드 E를 포함하는 인슐린 저항성 또는 인슐린 저항성 관련 질환의 예방 또는 치료용 조성물
    3.
    发明公开
    엘루테로사이드 E를 포함하는 인슐린 저항성 또는 인슐린 저항성 관련 질환의 예방 또는 치료용 조성물 无效
    用于预防或治疗包含ELEUTHEROSIDE E的胰岛素抵抗或胰岛素抵抗相关疾病的组合物

    公开(公告)号:KR1020130125226A

    公开(公告)日:2013-11-18

    申请号:KR1020120048806

    申请日:2012-05-08

    Abstract: The present invention relates to a pharmaceutical composition and a health food containing eleutheroside E for preventing or treating insulin resistance or insulin resistance-related diseases. The compositions show significant effects in blood glucose regulation, glucose tolerance improvement, insulin resistance improvement, and insulin reduction in blood, thereby preventing and treating insulin resistance or insulin resistance-related diseases. [Reference numerals] (AA,DD) Diabetes group;(BB) Diabetes group +E. senticosus;(CC) Diabetes group + Eleutherosld E;(EE) Diabetes group +E. senticosus;(FF) Diabetes group +Eleutheroside E

    Abstract translation: 本发明涉及药物组合物和含有用于预防或治疗胰岛素抵抗或胰岛素抵抗相关疾病的益胆素E的保健食品。 该组合物显示血糖调节,葡萄糖耐量改善,胰岛素抵抗改善和血液中胰岛素减少的显着影响,从而预防和治疗胰岛素抵抗或胰岛素抵抗相关疾病。 (参考数字)(AA,DD)糖尿病组;(BB)糖尿病组+ E。 糖尿病组(CC)糖尿病组+ Eleutherosld E;(EE)糖尿病组+ E。 糖尿病(FF)糖尿病组+ Eleutheroside E

Patent Agency Ranking